Search Within

Vadim Divilov

  1. "Solid Tumor Oncology Division"
Formats
  1. Journal Article (2)
  2. Meeting Abstract (2)
Groups
  1. Center for Molecular Imaging and Biotechnology (4)
  2. Center for Pancreatic Cancer Research (4)
  3. Department of Medicine (4)
  4. GSK Faculty (4)
  5. Radiochemistry and Imaging Sciences Service (4)
  6. Radiology, Department of (4)

More Groups

People
  1. Jason Lewis (4)
  2. Nerissa Villegas (4)
  3. Jason Holland (3)
  4. Yelena Janjigian (3)
  5. Sean Carlin (2)
  6. David Kelsen (1)

More People

Years
  1. 2014 (1)
  2. 2013 (1)
  3. 2011 (2)
Publications
  1. Journal of Clinical Oncology (1)
  2. Journal of Labelled Compounds and Radiopharmaceuticals (1)
  3. Journal of Nuclear Medicine (1)
  4. Proceedings of the National Academy of Sciences of the United States of America (1)
Publishers
  1. American Society of Clinical Oncology (1)
  2. National Academy of Sciences (1)
  3. Society of Nuclear Medicine (1)
  4. Wiley Blackwell (1)

Results (4)

Export to EndNote / Excel | PubMed

Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Understanding the pharmacological properties of a metabolic PET tracer in prostate cancer
    Journal Article

    Viola-Villegas, N. T.; Carlin, S. D.; Ackerstaff, E.; Sevak, K. K.; Divilov, V.; Serganova, I.; Kruchevsky, N.; Anderson, M.; Blasberg, R. G.; Andreev, O. A.; more...
    Proceedings of the National Academy of Sciences of the United States of America (2014)

    Fulltext@MSK | Save
  • Monitoring afatinib treatment in HER2-positive gastric cancer with (18)F-FDG and (89)Zr-trastuzumab PET
    Journal Article

    Janjigian, Y. Y.; Viola-Villegas, N.; Holland, J. P.; Divilov, V.; Carlin, S. D.; Gomes DaGama, E. M.; Chiosis, G.; Carbonetti, G.; de Stanchina, E.; Lewis, J. S.
    Journal of Nuclear Medicine (2013)

    Fulltext@MSK | Save
  • Positron emission tomography (PET) with (89)Zr-labeled trastuzumab ((89)Zr-trastuzumab): Monitoring HER2 expression in HER2-positive gastric cancer in vivo
    Meeting Abstract

    Janjigian, Y. Y.; Villegas, N. T.; Holland, J. P.; Shah, M. A.; Divilov, V.; Kelsen, D. P.; Lewis, J. S.
    Journal of Clinical Oncology (2011)

    Fulltext@MSK | Save
  • Zr-89 labeled trastuzumab as an effective non-invasive diagnostic agent for delineating Her2/neu-positive gastric cancer
    Meeting Abstract

    Viola-Villegas, N.; Janjigian, Y. Y.; Holland, J. P.; Divilov, V.; Lewis, J. S.
    Journal of Labelled Compounds and Radiopharmaceuticals (2011)

    Fulltext@MSK | Save